| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $366.1M | +19.0% |
| Cost of Revenue | $177.2M | +13.9% |
| Gross Profit | $188.9M | +24.3% |
| R&D Expense | $98.8M | +11.6% |
| SG&A Expense | $51.8M | -14.8% |
| Operating Income | -$7.1M | +83.7% |
| Interest Expense | $4.9M | +0.5% |
| Pre-tax Income | $41.0M | +193.8% |
| Income Tax | $157K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $46.1M | -51.4% |
| Short-term Investments | $118.7M | +543.5% |
| Accounts Receivable | $56.8M | +3.4% |
| Inventory | $99.3M | +2.2% |
| Current Assets | $326.4M | +21.0% |
| Total Assets | $489.1M | +36.1% |
| Current Liabilities | $331.2M | +972.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $128.3M | +359.8% |
| Capital Expenditures | $17.1M | -8.0% |
| Investing Cash Flow | -$192.6M | -266.3% |
| Financing Cash Flow | $15.7M | +79.5% |
| Free Cash Flow | $111.2M | +263.6% |
| +148.8% |
| Net Income | $40.8M | +194.2% |
| EPS (Basic) | $1.46 | +190.1% |
| EPS (Diluted) | $1.39 | +185.8% |
| Long-term Debt |
| $281.9M |
| +0.0% |
| Total Liabilities | $339.2M | +4.3% |
| Stockholders' Equity | $149.9M | +339.1% |